153 related articles for article (PubMed ID: 34711619)
21. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
[TBL] [Abstract][Full Text] [Related]
22. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
He G; Wu L; Zheng Q; Jiang X
Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
[No Abstract] [Full Text] [Related]
24. Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.
Olivier KN; Shaw PA; Glaser TS; Bhattacharyya D; Fleshner M; Brewer CC; Zalewski CK; Folio LR; Siegelman JR; Shallom S; Park IK; Sampaio EP; Zelazny AM; Holland SM; Prevots DR
Ann Am Thorac Soc; 2014 Jan; 11(1):30-5. PubMed ID: 24460437
[TBL] [Abstract][Full Text] [Related]
25. HMGN2 regulates non-tuberculous mycobacteria survival via modulation of M1 macrophage polarization.
Wang X; Chen S; Ren H; Chen J; Li J; Wang Y; Hua Y; Wang X; Huang N
J Cell Mol Med; 2019 Dec; 23(12):7985-7998. PubMed ID: 31596045
[TBL] [Abstract][Full Text] [Related]
26. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex.
Koh WJ; Stout JE; Yew WW
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1141-8. PubMed ID: 25216826
[TBL] [Abstract][Full Text] [Related]
27. Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.
Negatu DA; Beuchel A; Madani A; Alvarez N; Chen C; Aragaw WW; Zimmerman MD; Laleu B; Gengenbacher M; Dartois V; Imming P; Dick T
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0067621. PubMed ID: 34001512
[TBL] [Abstract][Full Text] [Related]
28. Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
Aragaw WW; Roubert C; Fontaine E; Lagrange S; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0140021. PubMed ID: 34723632
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010004. PubMed ID: 28000919
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2014 Dec; (12):CD010004. PubMed ID: 25470304
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Dec; 12():CD010004. PubMed ID: 23235684
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
Daley CL; Iaccarino JM; Lange C; Cambau E; Wallace RJ; Andrejak C; Böttger EC; Brozek J; Griffith DE; Guglielmetti L; Huitt GA; Knight SL; Leitman P; Marras TK; Olivier KN; Santin M; Stout JE; Tortoli E; van Ingen J; Wagner D; Winthrop KL
Clin Infect Dis; 2020 Aug; 71(4):905-913. PubMed ID: 32797222
[TBL] [Abstract][Full Text] [Related]
33. An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.
Stephenson D; Perry A; Appleby MR; Lee D; Davison J; Johnston A; Jones AL; Nelson A; Bourke SJ; Thomas MF; De Soyza A; Lordan JL; Lumb J; Robb AE; Samuel JR; Walton KE; Perry JD
BMC Pulm Med; 2019 Jan; 19(1):19. PubMed ID: 30665395
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary
Pedersen AA; Fløe A; Løkke A; Hilberg O
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38103902
[TBL] [Abstract][Full Text] [Related]
35. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections.
Wallace RJ; Dukart G; Brown-Elliott BA; Griffith DE; Scerpella EG; Marshall B
J Antimicrob Chemother; 2014 Jul; 69(7):1945-53. PubMed ID: 24633206
[TBL] [Abstract][Full Text] [Related]
36. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.
Martiniano SL; Esther CR; Haworth CS; Kasperbauer SH; Zemanick ET; Caverly LJ
Pediatr Pulmonol; 2020 Feb; 55(2):521-525. PubMed ID: 31821718
[TBL] [Abstract][Full Text] [Related]
37. Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections.
Banaschewski B; Verma D; Pennings LJ; Zimmerman M; Ye Q; Gadawa J; Dartois V; Ordway D; van Ingen J; Ufer S; Stapleton K; Hofmann T
J Cyst Fibros; 2019 Sep; 18(5):714-720. PubMed ID: 31138497
[TBL] [Abstract][Full Text] [Related]
38. Increasing nontuberculous mycobacteria infection in cystic fibrosis.
Bar-On O; Mussaffi H; Mei-Zahav M; Prais D; Steuer G; Stafler P; Hananya S; Blau H
J Cyst Fibros; 2015 Jan; 14(1):53-62. PubMed ID: 24917112
[TBL] [Abstract][Full Text] [Related]
39. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
[TBL] [Abstract][Full Text] [Related]
40. Nontuberculous Mycobacteria in Cystic Fibrosis.
Richards CJ; Olivier KN
Semin Respir Crit Care Med; 2019 Dec; 40(6):737-750. PubMed ID: 31659731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
